Literature DB >> 17729081

Work in inflammatory and degenerative joint diseases.

C Gobelet1, F Luthi, A T Al-Khodairy, M A Chamberlain.   

Abstract

This article focuses on work disability and sick leave and their cost; it also discusses the value of vocational rehabilitation programmes in rheumatic conditions such as rheumatoid arthritis, ankylosing spondylitis, hip and knee osteoarthritis. It acknowledges the importance of work not only for the worker who has one of these diseases but also for the public purse. Much can be done to improve the health of the persons and reduce their disability and its impact in the workplace which will have an important effect on their and their family's quality of life. It is important that neither rehabilitation nor vocational rehabilitation are regarded as bolt-on activities after drug treatment but are seen as an integral part of effective management. Publications dealing with return to work are relatively common in rheumatoid arthritis, less common in ankylosing spondylitis and relatively rare in osteoarthritis. Vocational rehabilitation programmes should aim to facilitate job retention or, failing that, to improve the ability to return to work. The process must be started with in the health arena and it has to be recognised that slow or poor practice in the health service can jeopardise the patient's work potential.

Entities:  

Mesh:

Year:  2007        PMID: 17729081     DOI: 10.1080/09638280701315094

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  8 in total

1.  Prognostic factors for sustained work participation in early osteoarthritis: a follow-up study in the Cohort Hip and Cohort Knee (CHECK).

Authors:  Hendrik J Bieleman; Michiel F Reneman; K Wiepke Drossaers-Bakker; Johan W Groothoff; Frits G J Oosterveld
Journal:  J Occup Rehabil       Date:  2013-03

2.  Work participation and health status in early osteoarthritis of the hip and/or knee: a comparison between the Cohort Hip and Cohort Knee and the Osteoarthritis Initiative.

Authors:  H J Bieleman; F G J Oosterveld; J C M Oostveen; M F Reneman; J W Groothoff
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

3.  Functional capacity of people with early osteoarthritis: a comparison between subjects from the cohort hip and cohort knee (CHECK) and healthy ageing workers.

Authors:  H J Bieleman; M W van Ittersum; J W Groothoff; J C M Oostveen; F G J Oosterveld; C P van der Schans; R Soer; M F Reneman
Journal:  Int Arch Occup Environ Health       Date:  2010-05-21       Impact factor: 3.015

4.  The effect of disease site (knee, hip, hand, foot, lower back or neck) on employment reduction due to osteoarthritis.

Authors:  Eric C Sayre; Linda C Li; Jacek A Kopec; John M Esdaile; Sherry Bar; Jolanda Cibere
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

5.  Adaptation and validation of the Ankylosing Spondylitis Work Instability Scale (AS-WIS) for use in Turkey.

Authors:  Ayşe A Küçükdeveci; Şebnem Ataman; Aysun Genç; Şehim Kutlay; Atilla H Elhan; Derya Őztuna; Alan Tennant
Journal:  Rheumatol Int       Date:  2014-06-03       Impact factor: 2.631

6.  Rheumatoid arthritis: scientific development from a critical point of view.

Authors:  Norman Schöffel; Stefanie Mache; David Quarcoo; Cristian Scutaru; Karin Vitzthum; David A Groneberg; Michael Spallek
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631

7.  Self-reported functional status as predictor of observed functional capacity in subjects with early osteoarthritis of the hip and knee: a diagnostic study in the CHECK cohort.

Authors:  H J Bieleman; M F Reneman; M W van Ittersum; C P van der Schans; J W Groothoff; F G J Oosterveld
Journal:  J Occup Rehabil       Date:  2009-06-26

8.  Sick Leave and Costs in Active Workers with Chronic Osteoarthritis Pain in Spain: Outcomes of the OPIOIDS Real World Study.

Authors:  Antoni Sicras-Mainar; Juan Carlos Tornero-Tornero; Francisco Vargas-Negrín; Isabel Lizarraga; Aram Sicras-Navarro; Javier Rejas-Gutierrez
Journal:  Open Access Rheumatol       Date:  2022-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.